Data / Crowdfunding / Maryland / 20/20 Biolabs, Inc.
20/20 Biolabs, Inc.: crowdfunding raise on PicMii Crowdfunding LLC, $10,000 to $350,000 (2025)
20/20 Biolabs, Inc., a corporation in Gaithersburg, MD, filed a Form C with the SEC on December 12, 2025 to raise $10,000 to $350,000 in Convertible Promissory Notes through PicMii Crowdfunding LLC. The offering closed on December 13, 2025. In its most recent fiscal year it reported $1,752,343 in revenue and a net loss of $5,126,667, with 20 employees.
SpecStream is the live web data engine for teams and agents. It reads every Form C on SEC EDGAR each morning, and this page is that reading. Ask for your own cut (a portal, a state, a size, a revenue range) and new raises arrive in your sheet, CRM, Slack or agent as they land.
- Website
- 2020biolabs.com
- Funding portal
- PicMii Crowdfunding LLC
- Address
- 15810 GAITHER ROAD, SUITE 235 SUITE 235, Gaithersburg, MD 20877
- Legal form
- Corporation
- Jurisdiction
- DE
- Incorporated
- May 1, 2000
- SEC CIK
- 0001139685
Offering terms
From the amendment filed December 12, 2025.
- Security
- Convertible Promissory Notes
- Price
- $1.00
- Target
- $10,000
- Maximum
- $350,000
- Deadline
- December 13, 2025
- Portal compensation
- 4.9% of the final raised amount and an amount equal to the sum of the actual fees for the escrow account.
Financials
From the Form C/A filed December 12, 2025.
| Most recent fiscal year | Prior fiscal year | Source | |
|---|---|---|---|
| Revenue | $1,752,343 | $1,424,304 | sec.gov |
| Cost of goods sold | $1,373,432 | $1,315,166 | sec.gov |
| Net income | $-5,126,667 | $-6,391,309 | sec.gov |
| Taxes paid | $0 | $0 | sec.gov |
| Total assets | $3,584,408 | $6,367,828 | sec.gov |
| Cash | $1,784,009 | $4,089,461 | sec.gov |
| Accounts receivable | $135,272 | $68,834 | sec.gov |
| Short-term debt | $1,355,078 | $1,011,623 | sec.gov |
| Long-term debt | $723,848 | $1,068,713 | sec.gov |
Filings
| Filed | Filing | Target | Maximum | Deadline | Note | Source |
|---|---|---|---|---|---|---|
| December 12, 2025 | Amendment | $10,000 | $350,000 | December 13, 2025 | Extending the offering to December 13th, 2025. | sec.gov |
| November 26, 2025 | Amendment | $10,000 | $350,000 | December 12, 2025 | Extending the offering to December 12th, 2025. | sec.gov |
| November 4, 2025 | Amendment | $10,000 | $350,000 | December 5, 2025 | Extending the offering to December 5th, 2025. | sec.gov |
| October 30, 2025 | Offering | $10,000 | $350,000 | November 30, 2025 | sec.gov | |
| August 13, 2025 | Progress update | $10,000 | $700,000 | August 9, 2025 | As of 8/13/2025, $488,235 has been raised through 488,235 securities sold. | sec.gov |
| August 6, 2025 | Amendment | $10,000 | $700,000 | August 9, 2025 | This Amendment is to extend the offering to August 9th, 2025. | sec.gov |
| July 8, 2025 | Amendment | $10,000 | $700,000 | August 8, 2025 | 20/20 Biolabs is extending their offering to August 8th, 2025. | sec.gov |
| July 8, 2025 | Amendment | $10,000 | $700,000 | July 18, 2025 | A reverse merger agreement mentioned in the SEC filing is no longer occurring and was removed from the offering materials. | sec.gov |
| May 20, 2025 | Offering | $10,000 | $700,000 | July 18, 2025 | sec.gov | |
| May 20, 2025 | Annual report | Not listed | Not listed | sec.gov | ||
| May 6, 2024 | Offering | $50,000 | $5,000,000 | April 30, 2025 | sec.gov | |
| April 29, 2024 | Annual report | Not listed | Not listed | sec.gov | ||
| May 1, 2023 | Annual report | Not listed | Not listed | sec.gov | ||
| January 19, 2023 | Progress update | $9,995 | $4,999,995 | December 15, 2022 | At the close of the offering, the issuer closed on $219,977.96 and 167 number of securities. | sec.gov |
| November 14, 2022 | Amendment | $9,995 | $4,999,995 | December 15, 2022 | Issuer is extending campaign end date | sec.gov |
| August 15, 2022 | Offering | $9,995 | $4,999,995 | November 15, 2022 | sec.gov | |
| July 8, 2020 | Annual report | Not listed | Not listed | sec.gov | ||
| April 30, 2019 | Annual report | Not listed | Not listed | sec.gov | ||
| August 14, 2018 | Annual report | Not listed | Not listed | sec.gov | ||
| August 13, 2018 | Withdrawal | Not listed | Not listed | sec.gov | ||
| August 13, 2018 | Annual report | Not listed | Not listed | sec.gov | ||
| December 14, 2017 | Amendment | $74,999 | $1,070,000 | December 14, 2017 | This Amendment is filed to add the Webinar Transcript (Exhibit I) | sec.gov |
| October 30, 2017 | Amendment | $74,999 | $1,070,000 | December 14, 2017 | Correct nonmaterial typographical errors in the Company Summary, the Subscription Agreement and the Certificate of Designation of Series A-2 Preferred Stock, and make a nonmaterial clarification to Section 7.3 of the Certificate of Designation. | sec.gov |
| October 13, 2017 | Offering | $74,999 | $1,070,000 | December 14, 2017 | sec.gov |
Also on SpecStream
Updated December 12, 2025. Read from SEC EDGAR. Public domain (U.S. government work). Financials are as each company reported them in its Form C, unaudited unless the filing says otherwise. Websites are the ones the companies declared to the SEC. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.